SENP6: A Potential Drug Target and Biomarker (G26054)

Target Name: SENP6

NCBI ID: G26054

SENP6

SENP6: A Potential Drug Target and Biomarker

Sentrin-specific protease 6 (ISOFORM 1), also known as SENP6, is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It plays a crucial role in the regulation of insulin secretion and has been implicated in several diseases, including type 1 diabetes and neurodegenerative disorders. Therefore, targeting SENP6 has the potential to be a new drug target and biomarker.

SENP6 is a member of the sentinelin family, which includes a variety of structurally similar enzymes that are involved in the regulation of protein levels and degradation. These enzymes are known as sentinels and are involved in maintaining cellular homeostasis, including the regulation of cytoskeletal organization, cell signaling, and intracellular signaling pathways. SENP6 is a type of sentinel that is involved in the regulation of protein levels and has been implicated in the development and progression of several diseases.

SENP6 has been shown to play a role in the regulation of insulin secretion, which is a critical function for maintaining cellular homeostasis and promoting overall health. Insulin is a hormone that is produced by the pancreas and helps to regulate the levels of glucose in the blood. SENP6 has been shown to regulate the degradation of GLUT1, a protein that is involved in insulin secretion. By doing so, SENP6 helps to maintain the levels of GLUT1 and GLUT2, which are critical for insulin secretion.

In addition to its role in insulin secretion, SENP6 has also been shown to play a role in the regulation of cellular signaling pathways. SENP6 has been shown to be involved in the regulation of several signaling pathways, including the TGF-β pathway and the PI3K/Akt pathway. These pathways are involved in the regulation of cellular processes that are critical for cellular growth, differentiation, and survival.

SENP6 has also been shown to be involved in the regulation of cytoskeletal organization and cell signaling. SENP6 has been shown to play a role in the regulation of the actinin cytoskeleton, which is responsible for the maintenance of cell shape and the regulation of cell signaling. Additionally, SENP6 has been shown to play a role in the regulation of the microtubules, which are responsible for the regulation of cell signaling.

SENP6 has also been implicated in the development and progression of several neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease. These disorders are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles and neurodegenerate aggregates. SENP6 has been shown to be involved in the regulation of the production of neurofibrillary tangles and neurodegenerate aggregates, which may contribute to the development and progression of these disorders.

In conclusion, SENP6 is a protein that is involved in the regulation of insulin secretion, cellular signaling pathways, cytoskeletal organization, and the regulation of neurofibrillary tangles and neurodegenerate aggregates. These functions make SENP6 a potential drug target and biomarker for the development of neurodegenerative disorders. Further research is needed to fully understand the role of SENP6 in the regulation of insulin secretion and other cellular processes, as well as its potential as a drug target and biomarker.

Protein Name: SUMO Specific Peptidase 6

Functions: Protease that deconjugates SUMO1, SUMO2 and SUMO3 from targeted proteins. Processes preferentially poly-SUMO2 and poly-SUMO3 chains, but does not efficiently process SUMO1, SUMO2 and SUMO3 precursors. Deconjugates SUMO1 from RXRA, leading to transcriptional activation. Involved in chromosome alignment and spindle assembly, by regulating the kinetochore CENPH-CENPI-CENPK complex. Desumoylates PML and CENPI, protecting them from degradation by the ubiquitin ligase RNF4, which targets polysumoylated proteins for proteasomal degradation. Desumoylates also RPA1, thus preventing recruitment of RAD51 to the DNA damage foci to initiate DNA repair through homologous recombination

The "SENP6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SENP6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets